Ainos completes stock consolidation

Ainos (AIMD) announced the completion of a 1-for-5 stock consolidation, effective at the opening of trading on June 30, 2025. The move strengthens the Company’s capital structure, aligns with Nasdaq listing requirements, and positions Ainos to scale global commercial operations across its AI Nose platforms. Following a pivotal first half, Ainos is focused on executing across strategic pillars: Semiconductor Manufacturing with ASE – Pursue a multi-stage AI Nose rollout roadmap with ASE Technology Holding, beginning with approximately 1,400 units of AI Nose for field pilot, laying foundation to scale deployment to approximately 5,000 units Phase 1 and up 15,000 units in Phase 2, enabling next-generation VOC detection. Smart Factories in Asia with Kenmec – Plan scaling AI Nose and SLM into Kenmec Mechanical Engineering’s smart factory ecosystem, accelerating deployment of multimodal sensory intelligence across robotics, logistics and autonomous manufacturing. Robotics with ugo – Advance AI Nose field pilots in Japan with ugo for the world’s first service robot equipped with a sense of smell; begin field test across Japanese infrastructure sites, targeting utility, maintenance and airport scenarios. Senior care – Initiate large-scale AI Nose pilot deployment with partners in Japan; evaluate Taiwan opportunities. VELDONA Clinical Pipeline – Initiate human clinical trials in Taiwan for HIV-related oral warts and Sjogren’s syndrome following recent regulatory approval; continue veterinary trials for FCGS. Smell Language Model – Expand the proprietary scent dataset powering the smell language model, Ainos’ AI architecture that transforms scent into machine-readable Smell ID. The platform has achieved over 90% accuracy in classifying meat, food, and beverage samples, and is now being commercialized across industrial and healthcare settings.